EDGAR Filing Documents for 0001193125-23-076670

Form 8-K - Current report:

SEC Accession No. 0001193125-23-076670

Filing Date

2023-03-22

Accepted

2023-03-22 16:01:54

Documents

Period of Report

2023-03-21

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d450883d8k.htm iXBRL	8-K	41145
2	EX-4.1	d450883dex41.htm	EX-4.1	79406
3	EX-4.2	d450883dex42.htm	EX-4.2	93776
4	EX-5.1	d450883dex51.htm	EX-5.1	10041
5	EX-10.1	d450883dex101.htm	EX-10.1	198685
6	EX-99.1	d450883dex991.htm	EX-99.1	11083
10	GRAPHIC	g450883g0322054811604.jpg	GRAPHIC	2017
	Complete submission text file	0001193125-23-076670.txt		678963

Data Files

Seq	Description	Document	Type	Size
7	XBRL TAXONOMY EXTENSION SCHEMA	acer-20230321.xsd	EX-101.SCH	2848
8	XBRL TAXONOMY EXTENSION LABEL LINKBASE	acer-20230321_lab.xml	EX-101.LAB	18758
9	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	acer-20230321_pre.xml	EX-101.PRE	11709
12	EXTRACTED XBRL INSTANCE DOCUMENT	d450883d8k_htm.xml	XML	3485

Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458

Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458 (844) 902-6100

Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)